{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:10:26Z","timestamp":1787062226591,"version":"build-2736575974"},"reference-count":55,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570765"],"award-info":[{"award-number":["81570765"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the efficacy of insulin sensitizers on menstrual frequency, sex hormone, and metabolic parameters in overweight women with polycystic ovary syndrome (PCOS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched multiple databases from inception to September 2019 for randomized controlled trials. Network meta-analysis was conducted using multivariate random effects method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fourteen trials reporting on 619 women were included. Compared with metformin, metformin\u2005+\u2005thiazolidinediones (TZDs) was more superior in menstrual recovery (weighted mean difference [WMD] 3.68; 95% credibility interval [CrI], 1.65 to 8.20), metformin\u2005+\u2005 glucagon-like peptide-1 (GLP-1) receptor agonists was more effective in decreasing androstenedione (WMD \u22122.53; 95% CrI, \u22123.96 to \u22121.09), both metformin\u2005+\u2005GLP-1 receptor agonists (WMD 9.22; 95% CrI, 5.46 to 12.98) and metformin\u2005+\u2005TZDs (WMD 4.30; 95% CrI, 0.78 to 7.82) were more effective in increasing sex hormone\u2013binding globulin (SHBG), while TZDs were less effective in decreasing body mass index (BMI) (WMD 1.69; 95% CrI, 0.72 to 2.66). Compared with GLP-1 receptor agonists, metformin\u2005+\u2005GLP-1 receptor agonists was associated with higher SHBG (WMD 7.80; 95% CrI, 4.75 to 10.85), lower free testosterone (WMD \u22121.77; 95% CrI, \u22123.25 to \u22120.29), lower androstenedione (WMD \u22122.70; 95% CrI, \u22123.91 to \u22121.50) and lower fasting blood glucose (WMD \u22120.41; 95% CrI, \u22120.73 to \u22120.08).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>For overweight women with PCOS, both metformin combined with GLP-1 receptor agonists and metformin combined with TZDs appear superior to monotherapy in improving hyperandrogenemia. Metformin combined with TZDs could be particularly effective in promoting the recovery of menstruation. Metformin combined with GLP-1 receptor agonists has the additional advantage of improving fasting glucose when compared with GLP-1 receptor agonists alone. TZDs are inferior to metformin in decreasing BMI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaa337","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T08:43:29Z","timestamp":1591173809000},"page":"2950-2963","source":"Crossref","is-referenced-by-count":63,"title":["Insulin Sensitizers for Improving the Endocrine and Metabolic Profile in Overweight Women With PCOS"],"prefix":"10.1210","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1375-4958","authenticated-orcid":false,"given":"Chuan","family":"Xing","sequence":"first","affiliation":[{"name":"The First Endocrinology Department of Shengjing Hospital of China Medical University, Shenyang"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunzhu","family":"Li","sequence":"additional","affiliation":[{"name":"The First Endocrinology Department of Shengjing Hospital of China Medical University, Shenyang"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9694-6591","authenticated-orcid":false,"given":"Bing","family":"He","sequence":"additional","affiliation":[{"name":"The First Endocrinology Department of Shengjing Hospital of China Medical University, Shenyang"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2020,6,3]]},"reference":[{"issue":"12","key":"2021122203022086300_CIT0001","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod."},{"key":"2021122203022086300_CIT0002","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ygcen.2017.12.007","article-title":"Evaluation of different ranges of LH:FSH ratios in polycystic ovarian syndrome (PCOS) - clinical based case control study","volume":"260","author":"Malini","year":"2018","journal-title":"Gen Comp Endocrinol."},{"issue":"2","key":"2021122203022086300_CIT0003","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1530\/REP-17-0584","article-title":"High-fat diet exposure from pre-pubertal age induces polycystic ovary syndrome (PCOS) in rats","volume":"155","author":"Patel","year":"2018","journal-title":"Reproduction."},{"issue":"2","key":"2021122203022086300_CIT0004","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/01443615.2017.1345875","article-title":"Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome","volume":"38","author":"Ates","year":"2018","journal-title":"J Obstet Gynaecol."},{"issue":"3","key":"2021122203022086300_CIT0005","doi-asserted-by":"crossref","first-page":"e0151960","DOI":"10.1371\/journal.pone.0151960","article-title":"Insulin resistance in PCOS patients enhances oxidative stress and leukocyte adhesion: role of myeloperoxidase","volume":"11","author":"Victor","year":"2016","journal-title":"PLoS One."},{"issue":"1","key":"2021122203022086300_CIT0006","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMcp1514916","article-title":"Polycystic ovary syndrome","volume":"375","author":"McCartney","year":"2016","journal-title":"N Engl J Med"},{"key":"2021122203022086300_CIT0007","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diabres.2017.06.011","article-title":"Insulin and the polycystic ovary syndrome","volume":"130","author":"Macut","year":"2017","journal-title":"Diabetes Res Clin Pract."},{"issue":"5","key":"2021122203022086300_CIT0008","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/humupd\/dmu012","article-title":"Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"20","author":"Barry","year":"2014","journal-title":"Hum Reprod Update."},{"issue":"1","key":"2021122203022086300_CIT0009","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000440810","article-title":"Body mass index below obesity threshold implies similar cardiovascular risk among various polycystic ovary syndrome phenotypes","volume":"25","author":"Bagir","year":"2016","journal-title":"Med Princ Pract."},{"issue":"11","key":"2021122203022086300_CIT0010","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1517\/14728222.2015.1101067","article-title":"Targets to treat metabolic syndrome in polycystic ovary syndrome","volume":"19","author":"Mahalingaiah","year":"2015","journal-title":"Expert Opin Ther Targets."},{"key":"2021122203022086300_CIT0011","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.lfs.2019.04.046","article-title":"Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS)","volume":"228","author":"Li","year":"2019","journal-title":"Life Sci."},{"issue":"3","key":"2021122203022086300_CIT0012","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00404-019-05210-z","article-title":"Effect of pretreatment with combined oral contraceptives on outcomes of assisted reproductive technology for women with polycystic ovary syndrome: a meta-analysis","volume":"300","author":"Song","year":"2019","journal-title":"Arch Gynecol Obstet."},{"issue":"3","key":"2021122203022086300_CIT0013","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/humupd\/dmv063","article-title":"Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis","volume":"22","author":"Naderpoor","year":"2016","journal-title":"Hum Reprod Update."},{"issue":"4","key":"2021122203022086300_CIT0014","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00404-018-4680-1","article-title":"Unilateral or bilateral laparoscopic ovarian drilling in polycystic ovary syndrome: a meta-analysis of randomized trials","volume":"297","author":"Abu Hashim","year":"2018","journal-title":"Arch Gynecol Obstet."},{"issue":"7","key":"2021122203022086300_CIT0015","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/jc.2008-0115","article-title":"Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome","volume":"93","author":"Elkind-Hirsch","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021122203022086300_CIT0016","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/EJE-08-0507","article-title":"Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome","volume":"159","author":"Jensterle","year":"2008","journal-title":"Eur J Endocrinol."},{"issue":"3","key":"2021122203022086300_CIT0017","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/EJE-13-0797","article-title":"Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin","volume":"170","author":"Jensterle Sever","year":"2014","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2021122203022086300_CIT0018","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF03401383","article-title":"A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome","volume":"14","author":"Jensterle","year":"2015","journal-title":"Hormones (Athens)."},{"key":"2021122203022086300_CIT0019","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13048-015-0161-3","article-title":"Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study","volume":"8","author":"Jensterle","year":"2015","journal-title":"J Ovarian Res."},{"issue":"4","key":"2021122203022086300_CIT0020","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3892\/etm.2016.3081","article-title":"Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: Randomized control study","volume":"11","author":"Jensterle","year":"2016","journal-title":"Exp Ther Med."},{"issue":"1","key":"2021122203022086300_CIT0021","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12902-017-0155-9","article-title":"Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial","volume":"17","author":"Jensterle","year":"2017","journal-title":"BMC Endocr Disord."},{"issue":"16","key":"2021122203022086300_CIT0022","first-page":"3887","article-title":"Efficacy of metformin and pioglitazone metformin in the treatment of obese polycystic ovary syndrome","author":"Li","year":"2017","journal-title":"J Maternal Child Health Care China"},{"issue":"2","key":"2021122203022086300_CIT0023","first-page":"148","article-title":"Effects of metformin and pioglitazone on sexual hormones and metabolic level in patients with polycystic ovary syndrome","author":"Liang","year":"2019","journal-title":"J Guangxi Med J."},{"issue":"3","key":"2021122203022086300_CIT0024","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2004-1965","article-title":"Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome","volume":"90","author":"Ortega-Gonz\u00e1lez","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2021122203022086300_CIT0025","doi-asserted-by":"crossref","first-page":"805","DOI":"10.4103\/2230-8210.192925","article-title":"Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome","volume":"20","author":"Shahebrahimi","year":"2016","journal-title":"Indian J Endocrinol Metab."},{"issue":"2","key":"2021122203022086300_CIT0026","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/193229680700100212","article-title":"Impact of treatment with rosiglitazone or metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome","volume":"1","author":"Steiner","year":"2007","journal-title":"J Diabetes Sci Technol."},{"issue":"02","key":"2021122203022086300_CIT0027","first-page":"181","article-title":"Metformin and pioglitazone plus metformin for patients with polycystic ovary syndrome combined with insulin resistance","author":"Wang","year":"2014","journal-title":"J Central South Pharmacy."},{"issue":"11","key":"2021122203022086300_CIT0028","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/BF03345339","article-title":"The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome","volume":"28","author":"Yilmaz","year":"2005","journal-title":"J Endocrinol Invest."},{"key":"2021122203022086300_CIT0029","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the cochrane handbook for systematic reviews of interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev."},{"issue":"5","key":"2021122203022086300_CIT0030","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/0272989X12458724","article-title":"Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials","volume":"33","author":"Dias","year":"2013","journal-title":"Med Decis Making."},{"key":"2021122203022086300_CIT0031","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol."},{"issue":"2","key":"2021122203022086300_CIT0032","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol."},{"issue":"5","key":"2021122203022086300_CIT0033","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev."},{"issue":"4","key":"2021122203022086300_CIT0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-14-0253","article-title":"The polycystic ovary syndrome: a position statement from the European Society of Endocrinology","volume":"171","author":"Conway","year":"2014","journal-title":"Eur J Endocrinol."},{"issue":"5","key":"2021122203022086300_CIT0035","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jpeds.2012.11.019","article-title":"Using the androgen excess-PCOS society criteria to diagnose polycystic ovary syndrome and the risk of metabolic syndrome in adolescents","volume":"162","author":"Roe","year":"2013","journal-title":"J Pediatr."},{"key":"2021122203022086300_CIT0036","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuropharm.2014.06.026","article-title":"Comparison of the independent and combined effects of sub-chronic therapy with metformin and a stable GLP-1 receptor agonist on cognitive function, hippocampal synaptic plasticity and metabolic control in high-fat fed mice","volume":"86","author":"Lennox","year":"2014","journal-title":"Neuropharmacology."},{"issue":"10","key":"2021122203022086300_CIT0037","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1742-1241.2006.01128.x","article-title":"Thiazolidinediones, insulin resistance and obesity: finding a balance","volume":"60","author":"Wilding","year":"2006","journal-title":"Int J Clin Pract."},{"issue":"5","key":"2021122203022086300_CIT0038","doi-asserted-by":"crossref","first-page":"e0126119","DOI":"10.1371\/journal.pone.0126119","article-title":"Liraglutide improves hypertension and metabolic perturbation in a rat model of polycystic ovarian syndrome","volume":"10","author":"Hoang","year":"2015","journal-title":"Plos One."},{"issue":"4","key":"2021122203022086300_CIT0039","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/humrep\/dep466","article-title":"Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response","volume":"25","author":"Palomba","year":"2010","journal-title":"Hum Reprod."},{"issue":"3","key":"2021122203022086300_CIT0040","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3109\/09513590.2012.736563","article-title":"Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome","volume":"29","author":"Nascimento","year":"2013","journal-title":"Gynecol Endocrinol."},{"issue":"9","key":"2021122203022086300_CIT0041","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1177\/1933719116635278","article-title":"Effects of exenatide on metabolic changes, sexual hormones, inflammatory cytokines, adipokines, and weight change in a DHEA-treated rat model","volume":"23","author":"Sun","year":"2016","journal-title":"Reprod Sci."},{"issue":"3","key":"2021122203022086300_CIT0042","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00404-015-3976-7","article-title":"A systematic review of GLP-1 agonists on the metabolic syndrome in women with polycystic ovaries","volume":"293","author":"Niafar","year":"2016","journal-title":"Arch Gynecol Obstet."},{"key":"2021122203022086300_CIT0043","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1477-7827-6-10","article-title":"Pioglitazone administration alters ovarian gene expression in aging obese lethal yellow mice","volume":"6","author":"Brannian","year":"2008","journal-title":"Reprod Biol Endocrinol."},{"issue":"2","key":"2021122203022086300_CIT0044","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.rbmo.2019.04.017","article-title":"GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis","volume":"39","author":"Han","year":"2019","journal-title":"Reprod Biomed Online."},{"issue":"3","key":"2021122203022086300_CIT0045","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2265.2010.03917.x","article-title":"Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis","volume":"74","author":"Li","year":"2011","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"11","key":"2021122203022086300_CIT0046","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4158\/EP15748.DSC","article-title":"American association of clinical endocrinologists, american college of endocrinology, and androgen excess and pcos society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome\u2013part 1","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract."},{"issue":"9","key":"2021122203022086300_CIT0047","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia."},{"issue":"9","key":"2021122203022086300_CIT0048","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.molmet.2014.09.005","article-title":"GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance","volume":"3","author":"Taher","year":"2014","journal-title":"Mol Metab."},{"issue":"7","key":"2021122203022086300_CIT0049","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/humrep\/deu114","article-title":"Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight\/obese women with polycystic ovary syndrome","volume":"29","author":"Ujvari","year":"2014","journal-title":"Hum Reprod."},{"issue":"4","key":"2021122203022086300_CIT0050","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1365-2265.2008.03204.x","article-title":"Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism","volume":"69","author":"Romualdi","year":"2008","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"2","key":"2021122203022086300_CIT0051","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00125-010-1937-z","article-title":"Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-\u03b1 in mice","volume":"54","author":"Maida","year":"2011","journal-title":"Diabetologia."},{"key":"2021122203022086300_CIT0052","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-nutr-071812-161201","article-title":"Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose","volume":"34","author":"Hayes","year":"2014","journal-title":"Annu Rev Nutr."},{"issue":"3","key":"2021122203022086300_CIT0053","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/dom.12593","article-title":"Gastrointestinal actions of glucagon-like peptide-1-based therapies: glycaemic control beyond the pancreas","volume":"18","author":"Smits","year":"2016","journal-title":"Diabetes Obes Metab."},{"issue":"7","key":"2021122203022086300_CIT0054","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1111\/jcmm.14366","article-title":"Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure","volume":"23","author":"Goltsman","year":"2019","journal-title":"J Cell Mol Med."},{"key":"2021122203022086300_CIT0055","author":"He","year":"2020"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa337\/33341253\/dgaa337.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/9\/2950\/41847121\/jcem_105_9_2950.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/9\/2950\/41847121\/jcem_105_9_2950.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T22:04:45Z","timestamp":1640124285000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/105\/9\/2950\/5850802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,3]]},"references-count":55,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,6,3]]},"published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa337","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9]]},"published":{"date-parts":[[2020,6,3]]}}}